Akari Therapeutics Plc (AKTX) - NASDAQ
Company Description
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which is focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded in 2005 and is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom